- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/16 - Cellules animales
Détention brevets de la classe C12N 5/16
Brevets de cette classe: 1315
Historique des publications depuis 10 ans
|
77
|
94
|
107
|
109
|
89
|
73
|
58
|
56
|
39
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19752 |
20 |
| Regeneron Pharmaceuticals, Inc. | 4182 |
17 |
| F. Hoffmann-La Roche AG | 7900 |
14 |
| The Trustees of the University of Pennsylvania | 4282 |
13 |
| Amgen Inc. | 4001 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6317 |
10 |
| Board of Regents, The University of Texas System | 5725 |
10 |
| The University of British Columbia | 1479 |
10 |
| Abbvie Inc. | 1786 |
9 |
| Arius Research Inc. | 21 |
9 |
| Crystal Bioscience Inc. | 82 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2544 |
9 |
| Genentech, Inc. | 3917 |
8 |
| CRISPR Therapeutics AG | 358 |
8 |
| CHO Plus, Inc. | 13 |
8 |
| Novartis AG | 10974 |
7 |
| The Trustees of Columbia University in the City of New York | 3551 |
7 |
| The Board of Trustees of the University of Illinois | 2693 |
7 |
| E. R. Squibb & Sons, L.L.C. | 120 |
7 |
| ImmunoGen, Inc. | 398 |
7 |
| Autres propriétaires | 1114 |